Respiratory syncytial virus prefusion F (RSVpreF) vaccine significantly reduced severe RSV-related lower respiratory tract disease (LRTD) requiring hospitalization or emergency department (ED ...

which is why there is a new vaccine each flu season. COVID-19 is caused by a coronavirus called SARS-CoV-2, which emerged late in 2019. The disease can also be caused by variants of the SARS-CoV-2 ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

to be used to prevent RSV-associated lower respiratory tract infection among infants and young children. Nirsevimab works differently from a traditional vaccine. The monoclonal antibody provides ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research. Researchers said the findings ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

The CDC recommends RSV vaccines for all adults ages 75 and older and adults ages 60 – 74 who are at increased risk for severe RSV. There are two immunizations recommended for infants ...

Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next month. The government's $174.5 million investment will ...